Global Rat Model

Rat Model Comprehensive Study by Type (Inbred, Outbred, Knockout, Hybrid, Others), Application (Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others), Production and Quality Control, Academics, Others), End Users (Human, Veterinary) Players and Region - Global Market Outlook to 2027

Rat Model Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Rat Model Market?

The rats are the most common species used for experimental purpose. These rat models are used to understand the disease mechanisms and preclinical testing of therapeutics. The cost effectiveness and ease of handling has enhanced the surgical procedures due to their large size. Moreover, the rats are the great model for cardiovascular disease, especially for stroke and hypertension. Therefore, the rising need of research and development are increasing the demand of rat models.

The market study is being classified by Type (Inbred, Outbred, Knockout, Hybrid and Others), by Application (Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others), Production and Quality Control, Academics and Others) and major geographies with country level break-up.

Envigo (United Kingdom), Charles River Laboratories International Inc. (United States), Taconic Biosciences Inc. (United States), The Jackson Laboratory (United States), Covance Inc. (United States), Janvier Labs (France), Harbour Antibodies Bv (United States), Transgenic Inc. (Japan), Genoway S.A. (France) and Sage Labs Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ingenious Targeting Laboratory (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Rat Model market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Rat Model market by Type, Application and Region.

On the basis of geography, the market of Rat Model has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Advantages over other organism such as mice. With each year passing, the rat models are used for research and developments. These are used on research for breast cancer and cardiovascular diseases which are better than mice. Further, they resemble the human disease as they are hormone receptive and premalignant stages. These factors contribute towards the higher demand of rat models than other organisms.

Market Trend
  • Growing Interests towards the Immune Compromised Rats

Restraints
  • Government Laws for the Ethical Use of Animals

Opportunities
  • Increasing Usage of Humanized Rat Models
  • Growing Production of Monoclonal Antibodies
  • Rising Demand of Personalized Humanized Rat Models Owing to the Growing Consumption of Personalized Medicines

Challenges
  • Alternative Methods of Animal Testing


Market Leaders and some development strategies
In April 2019, Charles River laboratories has acquired Citoxlab. This acquisition helps in the expansion of treatment option. Further, it strengthens the company’s position and expand the portfolio.
Envigo has announced its research model and services in India which is approved by association for assessment and accreditation of laboratory animal care.


Key Target Audience
Distributors and Traders, Research Organisations, Government Agencies and Organisations

Report Objectives / Segmentation Covered

By Type
  • Inbred
  • Outbred
  • Knockout
  • Hybrid
  • Others
By Application
  • Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others)
  • Production and Quality Control
  • Academics
  • Others
By End Users
  • Human
  • Veterinary

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Advantages over other organism such as mice. With each year passing, the rat models are used for research and developments. These are used on research for breast cancer and cardiovascular diseases which are better than mice. Further, they resemble the human disease as they are hormone receptive and premalignant stages. These factors contribute towards the higher demand of rat models than other organisms.
    • 3.3. Market Challenges
      • 3.3.1. Alternative Methods of Animal Testing
    • 3.4. Market Trends
      • 3.4.1. Growing Interests towards the Immune Compromised Rats
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rat Model, by Type, Application, End Users and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Rat Model (Value)
      • 5.2.1. Global Rat Model by: Type (Value)
        • 5.2.1.1. Inbred
        • 5.2.1.2. Outbred
        • 5.2.1.3. Knockout
        • 5.2.1.4. Hybrid
        • 5.2.1.5. Others
      • 5.2.2. Global Rat Model by: Application (Value)
        • 5.2.2.1. Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others)
        • 5.2.2.2. Production and Quality Control
        • 5.2.2.3. Academics
        • 5.2.2.4. Others
      • 5.2.3. Global Rat Model by: End Users (Value)
        • 5.2.3.1. Human
        • 5.2.3.2. Veterinary
      • 5.2.4. Global Rat Model Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Rat Model (Price)
      • 5.3.1. Global Rat Model by: Type (Price)
  • 6. Rat Model: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Envigo (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Charles River Laboratories International Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Taconic Biosciences Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. The Jackson Laboratory (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Covance Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Janvier Labs (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Harbour Antibodies Bv (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Transgenic Inc. (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genoway S.A. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sage Labs Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rat Model Sale, by Type, Application, End Users and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Rat Model (Value)
      • 7.2.1. Global Rat Model by: Type (Value)
        • 7.2.1.1. Inbred
        • 7.2.1.2. Outbred
        • 7.2.1.3. Knockout
        • 7.2.1.4. Hybrid
        • 7.2.1.5. Others
      • 7.2.2. Global Rat Model by: Application (Value)
        • 7.2.2.1. Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others)
        • 7.2.2.2. Production and Quality Control
        • 7.2.2.3. Academics
        • 7.2.2.4. Others
      • 7.2.3. Global Rat Model by: End Users (Value)
        • 7.2.3.1. Human
        • 7.2.3.2. Veterinary
      • 7.2.4. Global Rat Model Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Rat Model (Price)
      • 7.3.1. Global Rat Model by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rat Model: by Type(USD Million)
  • Table 2. Rat Model Inbred , by Region USD Million (2016-2021)
  • Table 3. Rat Model Outbred , by Region USD Million (2016-2021)
  • Table 4. Rat Model Knockout , by Region USD Million (2016-2021)
  • Table 5. Rat Model Hybrid , by Region USD Million (2016-2021)
  • Table 6. Rat Model Others , by Region USD Million (2016-2021)
  • Table 7. Rat Model: by Application(USD Million)
  • Table 8. Rat Model Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others) , by Region USD Million (2016-2021)
  • Table 9. Rat Model Production and Quality Control , by Region USD Million (2016-2021)
  • Table 10. Rat Model Academics , by Region USD Million (2016-2021)
  • Table 11. Rat Model Others , by Region USD Million (2016-2021)
  • Table 12. Rat Model: by End Users(USD Million)
  • Table 13. Rat Model Human , by Region USD Million (2016-2021)
  • Table 14. Rat Model Veterinary , by Region USD Million (2016-2021)
  • Table 15. South America Rat Model, by Country USD Million (2016-2021)
  • Table 16. South America Rat Model, by Type USD Million (2016-2021)
  • Table 17. South America Rat Model, by Application USD Million (2016-2021)
  • Table 18. South America Rat Model, by End Users USD Million (2016-2021)
  • Table 19. Brazil Rat Model, by Type USD Million (2016-2021)
  • Table 20. Brazil Rat Model, by Application USD Million (2016-2021)
  • Table 21. Brazil Rat Model, by End Users USD Million (2016-2021)
  • Table 22. Argentina Rat Model, by Type USD Million (2016-2021)
  • Table 23. Argentina Rat Model, by Application USD Million (2016-2021)
  • Table 24. Argentina Rat Model, by End Users USD Million (2016-2021)
  • Table 25. Rest of South America Rat Model, by Type USD Million (2016-2021)
  • Table 26. Rest of South America Rat Model, by Application USD Million (2016-2021)
  • Table 27. Rest of South America Rat Model, by End Users USD Million (2016-2021)
  • Table 28. Asia Pacific Rat Model, by Country USD Million (2016-2021)
  • Table 29. Asia Pacific Rat Model, by Type USD Million (2016-2021)
  • Table 30. Asia Pacific Rat Model, by Application USD Million (2016-2021)
  • Table 31. Asia Pacific Rat Model, by End Users USD Million (2016-2021)
  • Table 32. China Rat Model, by Type USD Million (2016-2021)
  • Table 33. China Rat Model, by Application USD Million (2016-2021)
  • Table 34. China Rat Model, by End Users USD Million (2016-2021)
  • Table 35. Japan Rat Model, by Type USD Million (2016-2021)
  • Table 36. Japan Rat Model, by Application USD Million (2016-2021)
  • Table 37. Japan Rat Model, by End Users USD Million (2016-2021)
  • Table 38. India Rat Model, by Type USD Million (2016-2021)
  • Table 39. India Rat Model, by Application USD Million (2016-2021)
  • Table 40. India Rat Model, by End Users USD Million (2016-2021)
  • Table 41. South Korea Rat Model, by Type USD Million (2016-2021)
  • Table 42. South Korea Rat Model, by Application USD Million (2016-2021)
  • Table 43. South Korea Rat Model, by End Users USD Million (2016-2021)
  • Table 44. Taiwan Rat Model, by Type USD Million (2016-2021)
  • Table 45. Taiwan Rat Model, by Application USD Million (2016-2021)
  • Table 46. Taiwan Rat Model, by End Users USD Million (2016-2021)
  • Table 47. Australia Rat Model, by Type USD Million (2016-2021)
  • Table 48. Australia Rat Model, by Application USD Million (2016-2021)
  • Table 49. Australia Rat Model, by End Users USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Rat Model, by Type USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Rat Model, by Application USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Rat Model, by End Users USD Million (2016-2021)
  • Table 53. Europe Rat Model, by Country USD Million (2016-2021)
  • Table 54. Europe Rat Model, by Type USD Million (2016-2021)
  • Table 55. Europe Rat Model, by Application USD Million (2016-2021)
  • Table 56. Europe Rat Model, by End Users USD Million (2016-2021)
  • Table 57. Germany Rat Model, by Type USD Million (2016-2021)
  • Table 58. Germany Rat Model, by Application USD Million (2016-2021)
  • Table 59. Germany Rat Model, by End Users USD Million (2016-2021)
  • Table 60. France Rat Model, by Type USD Million (2016-2021)
  • Table 61. France Rat Model, by Application USD Million (2016-2021)
  • Table 62. France Rat Model, by End Users USD Million (2016-2021)
  • Table 63. Italy Rat Model, by Type USD Million (2016-2021)
  • Table 64. Italy Rat Model, by Application USD Million (2016-2021)
  • Table 65. Italy Rat Model, by End Users USD Million (2016-2021)
  • Table 66. United Kingdom Rat Model, by Type USD Million (2016-2021)
  • Table 67. United Kingdom Rat Model, by Application USD Million (2016-2021)
  • Table 68. United Kingdom Rat Model, by End Users USD Million (2016-2021)
  • Table 69. Netherlands Rat Model, by Type USD Million (2016-2021)
  • Table 70. Netherlands Rat Model, by Application USD Million (2016-2021)
  • Table 71. Netherlands Rat Model, by End Users USD Million (2016-2021)
  • Table 72. Rest of Europe Rat Model, by Type USD Million (2016-2021)
  • Table 73. Rest of Europe Rat Model, by Application USD Million (2016-2021)
  • Table 74. Rest of Europe Rat Model, by End Users USD Million (2016-2021)
  • Table 75. MEA Rat Model, by Country USD Million (2016-2021)
  • Table 76. MEA Rat Model, by Type USD Million (2016-2021)
  • Table 77. MEA Rat Model, by Application USD Million (2016-2021)
  • Table 78. MEA Rat Model, by End Users USD Million (2016-2021)
  • Table 79. Middle East Rat Model, by Type USD Million (2016-2021)
  • Table 80. Middle East Rat Model, by Application USD Million (2016-2021)
  • Table 81. Middle East Rat Model, by End Users USD Million (2016-2021)
  • Table 82. Africa Rat Model, by Type USD Million (2016-2021)
  • Table 83. Africa Rat Model, by Application USD Million (2016-2021)
  • Table 84. Africa Rat Model, by End Users USD Million (2016-2021)
  • Table 85. North America Rat Model, by Country USD Million (2016-2021)
  • Table 86. North America Rat Model, by Type USD Million (2016-2021)
  • Table 87. North America Rat Model, by Application USD Million (2016-2021)
  • Table 88. North America Rat Model, by End Users USD Million (2016-2021)
  • Table 89. United States Rat Model, by Type USD Million (2016-2021)
  • Table 90. United States Rat Model, by Application USD Million (2016-2021)
  • Table 91. United States Rat Model, by End Users USD Million (2016-2021)
  • Table 92. Canada Rat Model, by Type USD Million (2016-2021)
  • Table 93. Canada Rat Model, by Application USD Million (2016-2021)
  • Table 94. Canada Rat Model, by End Users USD Million (2016-2021)
  • Table 95. Mexico Rat Model, by Type USD Million (2016-2021)
  • Table 96. Mexico Rat Model, by Application USD Million (2016-2021)
  • Table 97. Mexico Rat Model, by End Users USD Million (2016-2021)
  • Table 98. Rat Model: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Rat Model: by Type(USD Million)
  • Table 110. Rat Model Inbred , by Region USD Million (2022-2027)
  • Table 111. Rat Model Outbred , by Region USD Million (2022-2027)
  • Table 112. Rat Model Knockout , by Region USD Million (2022-2027)
  • Table 113. Rat Model Hybrid , by Region USD Million (2022-2027)
  • Table 114. Rat Model Others , by Region USD Million (2022-2027)
  • Table 115. Rat Model: by Application(USD Million)
  • Table 116. Rat Model Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others) , by Region USD Million (2022-2027)
  • Table 117. Rat Model Production and Quality Control , by Region USD Million (2022-2027)
  • Table 118. Rat Model Academics , by Region USD Million (2022-2027)
  • Table 119. Rat Model Others , by Region USD Million (2022-2027)
  • Table 120. Rat Model: by End Users(USD Million)
  • Table 121. Rat Model Human , by Region USD Million (2022-2027)
  • Table 122. Rat Model Veterinary , by Region USD Million (2022-2027)
  • Table 123. South America Rat Model, by Country USD Million (2022-2027)
  • Table 124. South America Rat Model, by Type USD Million (2022-2027)
  • Table 125. South America Rat Model, by Application USD Million (2022-2027)
  • Table 126. South America Rat Model, by End Users USD Million (2022-2027)
  • Table 127. Brazil Rat Model, by Type USD Million (2022-2027)
  • Table 128. Brazil Rat Model, by Application USD Million (2022-2027)
  • Table 129. Brazil Rat Model, by End Users USD Million (2022-2027)
  • Table 130. Argentina Rat Model, by Type USD Million (2022-2027)
  • Table 131. Argentina Rat Model, by Application USD Million (2022-2027)
  • Table 132. Argentina Rat Model, by End Users USD Million (2022-2027)
  • Table 133. Rest of South America Rat Model, by Type USD Million (2022-2027)
  • Table 134. Rest of South America Rat Model, by Application USD Million (2022-2027)
  • Table 135. Rest of South America Rat Model, by End Users USD Million (2022-2027)
  • Table 136. Asia Pacific Rat Model, by Country USD Million (2022-2027)
  • Table 137. Asia Pacific Rat Model, by Type USD Million (2022-2027)
  • Table 138. Asia Pacific Rat Model, by Application USD Million (2022-2027)
  • Table 139. Asia Pacific Rat Model, by End Users USD Million (2022-2027)
  • Table 140. China Rat Model, by Type USD Million (2022-2027)
  • Table 141. China Rat Model, by Application USD Million (2022-2027)
  • Table 142. China Rat Model, by End Users USD Million (2022-2027)
  • Table 143. Japan Rat Model, by Type USD Million (2022-2027)
  • Table 144. Japan Rat Model, by Application USD Million (2022-2027)
  • Table 145. Japan Rat Model, by End Users USD Million (2022-2027)
  • Table 146. India Rat Model, by Type USD Million (2022-2027)
  • Table 147. India Rat Model, by Application USD Million (2022-2027)
  • Table 148. India Rat Model, by End Users USD Million (2022-2027)
  • Table 149. South Korea Rat Model, by Type USD Million (2022-2027)
  • Table 150. South Korea Rat Model, by Application USD Million (2022-2027)
  • Table 151. South Korea Rat Model, by End Users USD Million (2022-2027)
  • Table 152. Taiwan Rat Model, by Type USD Million (2022-2027)
  • Table 153. Taiwan Rat Model, by Application USD Million (2022-2027)
  • Table 154. Taiwan Rat Model, by End Users USD Million (2022-2027)
  • Table 155. Australia Rat Model, by Type USD Million (2022-2027)
  • Table 156. Australia Rat Model, by Application USD Million (2022-2027)
  • Table 157. Australia Rat Model, by End Users USD Million (2022-2027)
  • Table 158. Rest of Asia-Pacific Rat Model, by Type USD Million (2022-2027)
  • Table 159. Rest of Asia-Pacific Rat Model, by Application USD Million (2022-2027)
  • Table 160. Rest of Asia-Pacific Rat Model, by End Users USD Million (2022-2027)
  • Table 161. Europe Rat Model, by Country USD Million (2022-2027)
  • Table 162. Europe Rat Model, by Type USD Million (2022-2027)
  • Table 163. Europe Rat Model, by Application USD Million (2022-2027)
  • Table 164. Europe Rat Model, by End Users USD Million (2022-2027)
  • Table 165. Germany Rat Model, by Type USD Million (2022-2027)
  • Table 166. Germany Rat Model, by Application USD Million (2022-2027)
  • Table 167. Germany Rat Model, by End Users USD Million (2022-2027)
  • Table 168. France Rat Model, by Type USD Million (2022-2027)
  • Table 169. France Rat Model, by Application USD Million (2022-2027)
  • Table 170. France Rat Model, by End Users USD Million (2022-2027)
  • Table 171. Italy Rat Model, by Type USD Million (2022-2027)
  • Table 172. Italy Rat Model, by Application USD Million (2022-2027)
  • Table 173. Italy Rat Model, by End Users USD Million (2022-2027)
  • Table 174. United Kingdom Rat Model, by Type USD Million (2022-2027)
  • Table 175. United Kingdom Rat Model, by Application USD Million (2022-2027)
  • Table 176. United Kingdom Rat Model, by End Users USD Million (2022-2027)
  • Table 177. Netherlands Rat Model, by Type USD Million (2022-2027)
  • Table 178. Netherlands Rat Model, by Application USD Million (2022-2027)
  • Table 179. Netherlands Rat Model, by End Users USD Million (2022-2027)
  • Table 180. Rest of Europe Rat Model, by Type USD Million (2022-2027)
  • Table 181. Rest of Europe Rat Model, by Application USD Million (2022-2027)
  • Table 182. Rest of Europe Rat Model, by End Users USD Million (2022-2027)
  • Table 183. MEA Rat Model, by Country USD Million (2022-2027)
  • Table 184. MEA Rat Model, by Type USD Million (2022-2027)
  • Table 185. MEA Rat Model, by Application USD Million (2022-2027)
  • Table 186. MEA Rat Model, by End Users USD Million (2022-2027)
  • Table 187. Middle East Rat Model, by Type USD Million (2022-2027)
  • Table 188. Middle East Rat Model, by Application USD Million (2022-2027)
  • Table 189. Middle East Rat Model, by End Users USD Million (2022-2027)
  • Table 190. Africa Rat Model, by Type USD Million (2022-2027)
  • Table 191. Africa Rat Model, by Application USD Million (2022-2027)
  • Table 192. Africa Rat Model, by End Users USD Million (2022-2027)
  • Table 193. North America Rat Model, by Country USD Million (2022-2027)
  • Table 194. North America Rat Model, by Type USD Million (2022-2027)
  • Table 195. North America Rat Model, by Application USD Million (2022-2027)
  • Table 196. North America Rat Model, by End Users USD Million (2022-2027)
  • Table 197. United States Rat Model, by Type USD Million (2022-2027)
  • Table 198. United States Rat Model, by Application USD Million (2022-2027)
  • Table 199. United States Rat Model, by End Users USD Million (2022-2027)
  • Table 200. Canada Rat Model, by Type USD Million (2022-2027)
  • Table 201. Canada Rat Model, by Application USD Million (2022-2027)
  • Table 202. Canada Rat Model, by End Users USD Million (2022-2027)
  • Table 203. Mexico Rat Model, by Type USD Million (2022-2027)
  • Table 204. Mexico Rat Model, by Application USD Million (2022-2027)
  • Table 205. Mexico Rat Model, by End Users USD Million (2022-2027)
  • Table 206. Rat Model: by Type(USD/Units)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rat Model: by Type USD Million (2016-2021)
  • Figure 5. Global Rat Model: by Application USD Million (2016-2021)
  • Figure 6. Global Rat Model: by End Users USD Million (2016-2021)
  • Figure 7. South America Rat Model Share (%), by Country
  • Figure 8. Asia Pacific Rat Model Share (%), by Country
  • Figure 9. Europe Rat Model Share (%), by Country
  • Figure 10. MEA Rat Model Share (%), by Country
  • Figure 11. North America Rat Model Share (%), by Country
  • Figure 12. Global Rat Model: by Type USD/Units (2016-2021)
  • Figure 13. Global Rat Model share by Players 2021 (%)
  • Figure 14. Global Rat Model share by Players (Top 3) 2021(%)
  • Figure 15. Global Rat Model share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Envigo (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Envigo (United Kingdom) Revenue: by Geography 2021
  • Figure 19. Charles River Laboratories International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Charles River Laboratories International Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Taconic Biosciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Taconic Biosciences Inc. (United States) Revenue: by Geography 2021
  • Figure 23. The Jackson Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 24. The Jackson Laboratory (United States) Revenue: by Geography 2021
  • Figure 25. Covance Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Covance Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Janvier Labs (France) Revenue, Net Income and Gross profit
  • Figure 28. Janvier Labs (France) Revenue: by Geography 2021
  • Figure 29. Harbour Antibodies Bv (United States) Revenue, Net Income and Gross profit
  • Figure 30. Harbour Antibodies Bv (United States) Revenue: by Geography 2021
  • Figure 31. Transgenic Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Transgenic Inc. (Japan) Revenue: by Geography 2021
  • Figure 33. Genoway S.A. (France) Revenue, Net Income and Gross profit
  • Figure 34. Genoway S.A. (France) Revenue: by Geography 2021
  • Figure 35. Sage Labs Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Sage Labs Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Global Rat Model: by Type USD Million (2022-2027)
  • Figure 38. Global Rat Model: by Application USD Million (2022-2027)
  • Figure 39. Global Rat Model: by End Users USD Million (2022-2027)
  • Figure 40. South America Rat Model Share (%), by Country
  • Figure 41. Asia Pacific Rat Model Share (%), by Country
  • Figure 42. Europe Rat Model Share (%), by Country
  • Figure 43. MEA Rat Model Share (%), by Country
  • Figure 44. North America Rat Model Share (%), by Country
  • Figure 45. Global Rat Model: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Envigo (United Kingdom)
  • Charles River Laboratories International Inc. (United States)
  • Taconic Biosciences Inc. (United States)
  • The Jackson Laboratory (United States)
  • Covance Inc. (United States)
  • Janvier Labs (France)
  • Harbour Antibodies Bv (United States)
  • Transgenic Inc. (Japan)
  • Genoway S.A. (France)
  • Sage Labs Inc. (United States)
Additional players considered in the study are as follows:
Ingenious Targeting Laboratory (United States)
Select User Access Type

Key Highlights of Report


Mar 2022 239 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rat Model Quantitative research analysis
Global Rat Model Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Advantages over other organism such as mice. With each year passing, the rat models are used for research and developments. These are used on research for breast cancer and cardiovascular diseases which are better than mice. Further, they resemble the human disease as they are hormone receptive and premalignant stages. These factors contribute towards the higher demand of rat models than other organisms." is seen as one of major growth factors of Rat Model Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Rat Model Market in coming years.

Know More About Global Rat Model Report?

Have a Query? Click Here

Other Related Reports

Biomarker Comprehensive Study by Type (Safety Biomarkers, Efficacy Biomarkers (Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers, Surrogate Biomarkers), Validation Biomarkers),...
$ 3750
Oral Proteins and Peptides Comprehensive Study by Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disor...
$ 3650
Platelet Rich Plasma Comprehensive Study by Type (Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Fibrin (L-PRF), Leukocyte-Platelet Rich Plasma (L-PRP)), Application (Orthopedics, Sports ...
$ 3650
White Biotechnology Comprehensive Study by Type (Biofuels, Biomaterials, Biochemicals, Industrial Enzymes), Application (Bioenergy, Food & Feed Additives, Pharmaceutical Ingredients, Personal Care & ...
$ 3750
Agricultural Biotechnology Comprehensive Study by Type (Genome editing tools, Deoxy ribonucleic acid (DNA) sequencing, Ribonucleic acid interference (RNAi), Synthetic biology, Biochips), Application ...
$ 3350
CD40 Ligand Comprehensive Study by Type (ISF-35, LOAd-700, MEDI-4920, MegaCD40L, Other), Application (Hepatitis B, Bladder Cancer, Liver Cancer, Ovarian Cancer, Others) Players and Region - Global Ma...
$ 3500